Keros Therapeutics Inc (KROS)

Revenue

$15.01M

TTM · Period ending: · USD

KROS logo

KROS Revenue

Latest reported$15.01M
KROS Revenue ($10.00M → $15.01M)
High-resolution chart · PNG

KROS revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Revenue — Annual fiscal periods (USD)
Period endingRevenue (USD)
244,061,000
3,550,000
151,000
0
20,100,000
0
10,000,000
10,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.